Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis Factors in Inflammatory Bowel Disease
PMID: 39158155
Source: Am J Gastroenterol
Publication date:
2025-07-24
Year:
2025
Abstract
NULL